/A
Phase 1
Active, not recruiting
- Conditions
- Therapeutic area: Diseases [C] - Cancer [C04]
- Registration Number
- EUCTR2011-005436-26-FR
- Lead Sponsor
- Fédération Francophone de Cancérologie Digestive
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 25
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 20
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms are being investigated in the Fédération Francophone de Cancérologie Digestive phase I cancer trial EUCTR2011-005436-26-FR?
How does the intervention in EUCTR2011-005436-26-FR compare to standard-of-care treatments for digestive system cancers in phase I trials?
What biomarkers are used for patient selection in the Fédération Francophone de Cancérologie Digestive phase I trial EUCTR2011-005436-26-FR?
What adverse events have been reported in similar phase I cancer trials sponsored by the Fédération Francophone de Cancérologie Digestive?
Are there any combination therapies or competitor drugs being studied alongside the intervention in EUCTR2011-005436-26-FR for digestive cancers?